Article Information
History
- December 18, 2020.
Article Versions
- Version 1 (April 23, 2020 - 23:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Karel Bezstarosti1,
- Mart M. Lamers2,
- Jeroen J. A. van Kampen2,
- Bart L. Haagmans2 and
- Jeroen A. A. Demmers1,*
- 1Proteomics Center, Erasmus University Medical Center, Rotterdam, the Netherlands
- 2Viroscience Department, Erasmus University Medical Center, Rotterdam, the Netherlands
- ↵*Correspondence: j.demmers{at}erasmusmc.nl (JAAD) | +31-10-7038124 | http://proteomics.center or http://proteomics.erasmusmc.nl
Posted December 18, 2020.
Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens
